Skip to main content
Clinical Trials/CTRI/2024/01/062023
CTRI/2024/01/062023
Not yet recruiting
Not Applicable

To study the effect of probiotics preparation Infloran® supplementation in on morbidities in Indian preterm neonates (PrISM)

Dr Nandini Desai Principle1 site in 1 country200 target enrollmentStarted: February 25, 2024Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Dr Nandini Desai Principle
Enrollment
200
Locations
1
Primary Endpoint
suspected or confirmed positive Bell state II or more (1)(2)

Overview

Brief Summary

Preterm infants born at the study site hospitals or referred to these hospitals will be enrolled in the study, if they satisfy all inclusion criteria and meet none of the exclusion criteria.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
None

Eligibility Criteria

Ages
1.00 Day(s) to 7.00 Day(s) (—)

Inclusion Criteria

  • Gestation: Preterm infants and neonates born at 32 weeks gestation or 32 to 36 weeks gestation Age at recruitment: within 7 days of age Weight: very low birth weight or lessthan 1500 grams Gender any.

Exclusion Criteria

  • Severe birth complications Malformation of the gut (omphalocele, gastroschisis, intestinal atresia) Chromosomal anomalies Neonates with central venous catheter Neonates on antifungal drugs.

Outcomes

Primary Outcomes

suspected or confirmed positive Bell state II or more (1)(2)

Time Frame: Day 42 after the birth

Secondary Outcomes

  • Culture positive sepsis: blood culture positive(Clinical sepsis: clinical features of sepsis without positive blood culture)
  • All-cause mortality(Day 42 after the birth)

Investigators

Sponsor
Dr Nandini Desai Principle
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Bhadresh R Vyas

M P Shah Medical College and G G Hospital, Jamnagar

Study Sites (1)

Loading locations...

Similar Trials